18

Biomarker-Guided HF Therapy: Is It Cost-Effective?

Embed Size (px)

DESCRIPTION

Biomarker-Guided HF Therapy: Is It Cost-Effective?. Age-Adjusted Hospitalization Rates for Heart Failure. Cost* of Heart Failure to Society. Diagnostic Uncertainty Is Associated With Poor Prognosis in Acute Dyspnea. - PowerPoint PPT Presentation

Citation preview

Page 1: Biomarker-Guided HF Therapy: Is It Cost-Effective?
Page 2: Biomarker-Guided HF Therapy: Is It Cost-Effective?
Page 3: Biomarker-Guided HF Therapy: Is It Cost-Effective?
Page 4: Biomarker-Guided HF Therapy: Is It Cost-Effective?
Page 5: Biomarker-Guided HF Therapy: Is It Cost-Effective?
Page 6: Biomarker-Guided HF Therapy: Is It Cost-Effective?
Page 7: Biomarker-Guided HF Therapy: Is It Cost-Effective?
Page 8: Biomarker-Guided HF Therapy: Is It Cost-Effective?
Page 9: Biomarker-Guided HF Therapy: Is It Cost-Effective?
Page 10: Biomarker-Guided HF Therapy: Is It Cost-Effective?
Page 11: Biomarker-Guided HF Therapy: Is It Cost-Effective?
Page 12: Biomarker-Guided HF Therapy: Is It Cost-Effective?
Page 13: Biomarker-Guided HF Therapy: Is It Cost-Effective?
Page 14: Biomarker-Guided HF Therapy: Is It Cost-Effective?
Page 15: Biomarker-Guided HF Therapy: Is It Cost-Effective?
Page 16: Biomarker-Guided HF Therapy: Is It Cost-Effective?
Page 17: Biomarker-Guided HF Therapy: Is It Cost-Effective?
Page 18: Biomarker-Guided HF Therapy: Is It Cost-Effective?